...

Read & Publish: 124% annual increase in the number of participating institutions in North America

2 March 2023

We are delighted to announce that the number of institutions in North America that are participating in our cost-neutral Read & Publish Open Access (OA) initiative increased by 124% between January 2022 and January 2023.

Over 130 institutions in Canada and the USA are now participating. We have signed agreements with library consortia in the USA, including the University of California, and more agreements are in the pipeline.

The number of Open Access articles funded by Read & Publish agreements with institutions in North America increased by more than 51% in 2022, and we are expecting further growth in 2023.

We are also delighted that a high proportion of libraries have opted to include our fully OA journals – Disease Models & Mechanisms and Biology Open – in their Read & Publish agreements in 2023.

Shelly Turner, Head of Sales and Business Development at The Company of Biologists:

“The impressive growth in North American institutions participating in our cost-neutral Read & Publish initiative is very encouraging, and I am looking forward to continuing discussions with librarians and library consortia during my visit to the USA this month.

I will be attending ER&L from 5-8 March, ACRL from 15-18 March, and the NAS Journal Summit on 22 March. I will also be visiting a range of institutions during my trip.”

Claire Moulton, Publisher, The Company of Biologists:

“It is great that the number of Open Access articles funded by Read & Publish agreements with institutions in North America increased by over 51% in 2022, and this helped us to meet our Transformative Journal targets for OA growth.

We have also had fantastic feedback from authors who have benefitted from immediate and fee-free OA publishing in both our hybrid and fully OA journals thanks to Read & Publish agreements with their institutions.”

About The Company of Biologists

The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community. We partner with libraries and library consortia to enable biologists worldwide to access our leading peer-reviewed hybrid journals: Development, Journal of Cell Science and Journal of Experimental Biology.

We have been committed to Open Access (OA) since 2004. We publish two fully OA journals – Disease Models & Mechanisms and Biology Open. Our hybrid journals were the first in the world to be afforded Transformative Journal status by Plan S and over 600 institutions in 39 countries are now participating in our cost-neutral Read & Publish OA initiative. We also have Read & Publish agreements with ten library consortia.

Any questions?

Read & Publish Open Access initiative

Available to libraries and library consortia worldwide, our Read & Publish agreements offer a cost-neutral transition to Open Access.

Read & Publish and Open Access video collection

Keep up to date with the latest library news and events

Our commitment to Open Access publishing goes back to 2004

Read & Publish for researchers

Learn how Read & Publish agreements benefit researchers. View our step-by-step guide to publishing Read & Publish Open Access research articles.


Visit our journal websites

Development Journal of Cell Science The Journal of Experimental Biology Disease Models & Mechanisms Biology Open

© 2024 The Company of Biologists Ltd | Registered Charity 277992
Registered in England and Wales | Company Limited by Guarantee No 514735
Registered office: Bidder Building, Station Road, Histon, Cambridge CB24 9LF, UK